Trial search - ClinicalTrials.eu

Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

↓

Matched clinical trials

Study of [18F]MC225 to Assess P-glycoprotein Function in Patients with Alzheimer’s, Mild Cognitive Impairment, and Parkinson’s Disease

Not yet recruiting

1 1
Investigated diseases:
Investigated drugs:
- [18F]Mc225
Study on Cannabis Extract for Improving Quality of Life in Patients with Alzheimer’s, Parkinson’s, or ALS Using Dronabinol and Cannabidiol

Not yet recruiting

1
Investigated diseases:
Investigated drugs:
- Cannabidiol
- Dronabinol
Study on the Effect of Clozapine on Immune Response in Patients with Parkinson’s Disease

Not yet recruiting

1 1 1 1
Investigated diseases:
- Parkinson’s disease
Investigated drugs:
- Clozapine
Safety Study of Afamelanotide for Patients with Early Parkinson’s Disease

Not yet recruiting

1 1
Investigated diseases:
- Parkinson’s disease
Investigated drugs:
- Afamelanotide
Comparative Bioavailability of Inhaled Levodopa (Levodopa Cyclops) versus Inhaled Levodopa Powder with Carbidopa in Healthy Adults for Parkinson’s Disease

Not recruiting

1 1 1
Investigated diseases:
- Parkinson’s disease
Investigated drugs:
- Carbidopa
- Levodopa
Comparing Skin Adhesiveness of a New Rotigotine 12 mg/24 h Transdermal Patch Versus Standard Treatment in Patients with Parkinson’s Disease

Not recruiting

1 1 1
Investigated diseases:
- Parkinson’s disease
Investigated drugs:
- Rotigotine
Study on the Expression of the 5-HT4 Receptor in Patients with Mild to Moderate Parkinson’s Disease Using [C11]-SB207145

Not recruiting

1 1 1
Investigated diseases:
- Parkinson’s disease
Investigated drugs:
- (1-(111C)METHYLPIPERIDIN-4-YL)METHYL 5-AMINO-6-CHLORO-1,4-BENZODIOXINE-8-CARBOXYLATE
Study of CVN424 for Reducing Motor Complications in Parkinson’s Disease Patients

Not recruiting

1
Investigated diseases:
- Parkinson’s disease
Investigated drugs:
- 1-[2-[4-(2,4-DIFLUOROPHENOXY)PIPERIDIN-1-YL]-3-[[(3R)-OXOLAN-3-YL]AMINO]-7,8-DIHYDRO-5H-PYRIDO[3,4-B]PYRAZIN-6-YL]ETHANONE
Study on the Safety and Effects of BIIB122 for Patients with LRRK2-Associated Parkinson’s Disease

Not recruiting

1
Investigated drugs:
- N2-(3-(2-(2H-1,2,3-Triazol-2-Yl)Propan-2-Yl)-1-Cyclopropyl-1H-Pyrazol-5-Yl)-N4-Ethyl-5-(Trifluoromethyl)Pyrimidine-2,4-Diamine
Study on the Effects and Safety of Prasinezumab for Patients with Early Parkinson’s Disease

Not recruiting

1 1
Investigated diseases:
- Parkinson’s disease
Investigated drugs:
- Prasinezumab

Find clinical trials in your area

Matched clinical trials

We use cookies